» Articles » PMID: 30629188

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-like Cells Through a Chemical Approach

Overview
Journal J Mol Cell Biol
Specialty Molecular Biology
Date 2019 Jan 11
PMID 30629188
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Transplantation of oligodendrocyte progenitor cells (OPCs) is a promising way for treating demyelinating diseases. However, generation of scalable and autologous sources of OPCs has proven difficult. We previously established a chemical condition M9 that could specifically initiate neural program in mouse embryonic fibroblasts. Here we found that M9 could induce the formation of colonies that undergo mesenchymal-to-epithelial transition at the early stage of reprogramming. These colonies may represent unstable and neural lineage-restricted intermediates that have not established a neural stem cell identity. By modulating the culture signaling recapitulating the principle of OPC development, these intermediate cells could be reprogrammed towards OPC fate. The chemical-induced OPC-like cells (ciOPLCs) resemble primary neural stem cell-derived OPCs in terms of their morphology, gene expression, and the ability of self-renewal. Upon differentiation, ciOPLCs could produce functional oligodendrocytes and myelinate the neuron axons in vitro, validating their OPC identity molecularly and functionally. Therefore, our study provides a non-integrating approach to OPC reprogramming that may ultimately provide an avenue to patient-specific cell-based or in situ regenerative therapy.

Citing Articles

Chemical transdifferentiation of somatic cells to neural cells: a systematic review.

Visintin P, Zampieri B, Griesi-Oliveira K Einstein (Sao Paulo). 2024; 22:eRW0423.

PMID: 39661857 PMC: 11634374. DOI: 10.31744/einstein_journal/2024RW0423.


Conversion of Astrocyte Cell Lines to Oligodendrocyte Progenitor Cells Using Small Molecules and Transplantation to Animal Model of Multiple Sclerosis.

Sharifi-Kelishadi M, Zare L, Fathollahi Y, Javan M J Mol Neurosci. 2024; 74(2):40.

PMID: 38594388 DOI: 10.1007/s12031-024-02206-6.


Glial-restricted progenitor cells: a cure for diseased brain?.

Rogujski P, Lukomska B, Janowski M, Stanaszek L Biol Res. 2024; 57(1):8.

PMID: 38475854 PMC: 10935984. DOI: 10.1186/s40659-024-00486-1.


Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges.

Chen J, Huang L, Yang Y, Xu W, Qin Q, Qin R Brain Sci. 2023; 13(3).

PMID: 36979334 PMC: 10046178. DOI: 10.3390/brainsci13030524.


The Journey of iPSC-derived OPCs in Demyelinating Disorders: From Generation to Transplantation.

Lohrasbi F, Ghasemi-Kasman M, Soghli N, Ghazvini S, Vaziri Z, Abdi S Curr Neuropharmacol. 2023; 21(9):1980-1991.

PMID: 36825702 PMC: 10514531. DOI: 10.2174/1570159X21666230220150010.


References
1.
Brustle O, Jones K, Learish R, Karram K, Choudhary K, Wiestler O . Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science. 1999; 285(5428):754-6. DOI: 10.1126/science.285.5428.754. View

2.
Kondo T, Raff M . Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science. 2000; 289(5485):1754-7. DOI: 10.1126/science.289.5485.1754. View

3.
Pringle N, Mudhar H, Collarini E, Richardson W . PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development. 1992; 115(2):535-51. DOI: 10.1242/dev.115.2.535. View

4.
Dawson M, Polito A, Levine J, Reynolds R . NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci. 2003; 24(2):476-88. DOI: 10.1016/s1044-7431(03)00210-0. View

5.
Sherman D, Brophy P . Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci. 2005; 6(9):683-90. DOI: 10.1038/nrn1743. View